Page 85 - Migraine, the heart and the brain

Right-to-left shunts and micro-embolization in migraine
23 Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 2010; 9:309 – 317.
24 Dinia L, Roccatagliata L, Bonzano L, et al. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache 2007; 47:1455– 1456.
25 Zaletel M, Zvan B, Kozelj M, et al. Migraine with aura induced by arti cial microbubbles. Cephalalgia
2009; 29:480 – 483.
26 Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast-transcranial Doppler: a trigger for migraine with aura? Headache 2010; 50:1320–1327.
27 Sorensen SG, Aguilar H, Reichert W, et al. Transient neurological symptoms during contrast transcranial Doppler right-to-left shunt testing in patients with cryptogenic neurological disease. J Interv Cardiol
2010; 23:284 – 290.
28 Morrison N, Neuhardt DL. Foam sclerotherapy: cardiac and cerebral monitoring. Phlebology 2009; 24:252 – 259.
29 Regan JD, Gibson KD, Rush JE, et al. Clinical signi cance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt. J Vasc Surg 2011; 53:131–137.
30 Sarvananthan T, She pherd AC, Willenberg T, Davies AH. Neurological complications of sclerotherapy for 4 varicose veins. J Vasc Surg 2012;55:243–251.
31 Frullini A, Felice F, Burchielli S, Di SR. High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 2011; 26:203 – 208.
32 Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao’s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002; 125:102– 112.
33 Mollerlokken A, Gaustad SE, Havnes MB, et al. Venous gas embolism as a predictive tool for improving CNS decompression safety. Eur J Appl Physiol 2012; 112:401–409.
34 Wilmshurst P, Bryson P. Relationship between the clinical features of neurological decompression illness and its causes. Clin Sci (Lond) 2000; 99:65 – 75.
35 Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993; 4:1027–1030.
36 Billinger M, Zbinden R, Mordasini R, et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up.Heart 2011; 97:1932–1937.
37 Riding G, Daly K, Hutchinson S, et al. Paradoxical cerebral embolisation. An explanation for fat embolism syndrome. J Bone Joint Surg Br 2004; 86:95 – 98.
38 Forteza AM, Koch S, Campo-Bustillo I, et al. Transcranial Doppler detection of cerebral fat emboli and relation to paradoxical embolism: a pilot study. Circulation 2011; 123:1947–1952.
39 Pierce CW. Platypnea-orthodeoxia syndrome in an elderly woman with a patent foramen ovale. Can J Cardiol 2010; 26:213 – 214.
40 Naqvi TZ, Ra e R, Daneshvar S. Original investigations. Potential faces of patent foramen ovale (PFO PFO). Echocardiography 2010; 27:897–907
41 Schoonman GG, Sandor PS, Agosti RM, et al. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia 2006;26: 816–819.
42 Dear WE, Chen P, Barasch E, et al. Sixty-eight-year-old woman with intermittent hypoxemia. Circulation 1995; 91:2284 – 2289.
43 Sallustio F, Di LS, Diomedi M, Stanzione P. Effect of a single oral dose of sildena l on right-to-left shunt. Cerebrovasc Dis 2011; 32:296 – 297.
44 MacLean MR, Dempsie Y. The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med
Biol 2010; 661:309 – 322.
45 Dao CN, Tobis JM. PFO and paradoxical embolism producing events other than stroke. Catheter Cardiovasc Interv 2011; 77:903–909.
46 Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr
Opin Neurol 2007; 20:310 – 319.
83